                               SEQUENCE LISTING

<110> CHILDREN'S MEDICAL CENTER CORPORATION
 
<120> METHODS OF ALTERING VASCULAR PERMEABILITY AND USES THEREOF

<130> 701039-077091-PCT

<140> PCT/US14/26975
<141> 2014-03-14

<150> 61/788,714
<151> 2013-03-15

<160> 7     

<170> PatentIn version 3.5

<210> 1
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Glu Asp Thr Ser Cys Asp Tyr Gly Tyr His Arg Arg Phe Ala 
1               5                   10                  


<210> 2
<211> 18
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
caacgggcag guguucag                                                     18


<210> 3
<211> 18
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
cugaacaccu gcccguug                                                     18


<210> 4
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
cagacgccac tgtcgcttt                                                    19


<210> 5
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
tgtctttgga actttgtctg caa                                               23


<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
tcttctgctg cgtgacaacc                                                   20


<210> 7
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
gagaaaccag cttggaacca g                                                 21


